000 | 01907 a2200517 4500 | ||
---|---|---|---|
005 | 20250515234735.0 | ||
264 | 0 | _c20110310 | |
008 | 201103s 0 0 eng d | ||
022 | _a1873-4995 | ||
024 | 7 |
_a10.1016/j.jconrel.2010.08.003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTakenaga, Mitsuko | |
245 | 0 | 0 |
_aNano PGE1 promoted the recovery from spinal cord injury-induced motor dysfunction through its accumulation and sustained release. _h[electronic resource] |
260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cDec 2010 |
||
300 |
_a249-54 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAlprostadil _xchemistry |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatocyte Growth Factor _xmetabolism |
650 | 0 | 4 | _aHindlimb |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aMotor Neurons _xdrug effects |
650 | 0 | 4 |
_aMuscle, Skeletal _xinnervation |
650 | 0 | 4 |
_aMyelin Basic Protein _xmetabolism |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRecovery of Function |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord Injuries _xdrug therapy |
650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
700 | 1 | _aIshihara, Tsutomu | |
700 | 1 | _aOhta, Yuki | |
700 | 1 | _aTokura, Yukie | |
700 | 1 | _aHamaguchi, Akemi | |
700 | 1 | _aIgarashi, Rie | |
700 | 1 | _aMizushima, Tohru | |
773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 148 _gno. 2 _gp. 249-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2010.08.003 _zAvailable from publisher's website |
999 |
_c20046405 _d20046405 |